rade 2 to 4 (adjusted OR, 0.18; 95% CI, .07–.43; P = .0001) With a duration of corticosteroids ≤5 days vs >5 days during inpatient admission (adjusted OR, 0.19; 95% CI, .10–.37; P < .0001) Female patients were also less likely to continue antifungal prophylaxis after discharge, but this association did not reach statistical significance (adjusted OR, 0.64; 95% CI, .40–1.04; P = .072).
← all excerpts
Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection.
1
0.0720
0.0720